The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
about
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetesKcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac deathPro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Hypoglycemic Coma Induced by the Use of Succinic Acid Cibenzoline in Frail Late-stage Elderly SubjectsManagement of Type 1 Diabetes in Older Adults.How to best manage glycemia and non-glycemia during the time of acute myocardial infarction.Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin.Remote Liver Ischemic Preconditioning Protects against Sudden Cardiac Death via an ERK/GSK-3β-Dependent Mechanism.Death during intensive glycemic therapy of diabetes: mechanisms and implications.Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Sudden cardiac death after myocardial infarction in type 2 diabetic patients with no residual myocardial ischemia.Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetesDiabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and InterventionsThe Effect of Glucose Variability on QTc Duration and Dispersion in Patients with Type 2 Diabetes Mellitus.Admission Glucose and In-hospital Mortality after Acute Myocardial Infarction in Patients with or without Diabetes: A Cross-sectional StudyMedically minimising the impact of hypoglycaemia in type 2 diabetes: a review.What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.Impact of hypoglycemia in hospitalized patients.Variability of glucose-lowering effect as a limiting factor in optimizing basal insulin therapy: a review.The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia.Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death.Diabetic Dead-in-Bed Syndrome: A Possible Link to a Cardiac Ion Channelopathy.Hypoglycemia affects the changes in endothelial progenitor cell levels during insulin therapy in type 2 diabetic patients.[Sudden cardiac death in diabetes mellitus].Inverse association between fasting plasma glucose and risk of ventricular arrhythmias.Hypoglycemia in type 2 diabetes: current controversies and changing practices.Poor glycaemic control and arrhythmias.Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus.Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians.Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.[Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma].Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study.Frequency of return visits to the emergency department in patients discharged following hypoglycemia episodes.Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka.Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of HypoglycaemiaManagement of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Salbutamol-induced electrophysiological changes show no correlation with electrophysiological changes during hyperinsulinaemic-hypoglycaemic clamp in young people with Type 1 diabetesCardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management
P2860
Q22241288-A6260DE2-0C05-4316-BCDA-B38771C2054AQ26827955-56FD73CD-1FB5-40F3-B79E-40C71641C503Q28305511-F439FCDE-A3E0-46AA-ABDA-502BBA80EED9Q30234356-A009D4E7-D402-4020-9598-06522D1DC90AQ33894735-E2AAF3D0-1152-4433-9CBA-34495F23DA33Q35910466-99CA66BF-E776-4D6A-9842-E2E58F8E58EAQ36072601-9901EB4C-C392-45E1-B419-84DAB67E2B07Q36169413-3C09AB31-E1B0-4958-96F5-6C4A7B23C53AQ36170828-67915D86-133C-4EFF-8045-D33F1FDD8F2FQ36297059-696C18B4-129D-4E09-9D57-298CF838A28AQ36382360-30F697D7-524A-4C5D-BEF4-E7CCC9E3D87DQ36426874-47729316-D3DC-4034-AA59-E3ED0F91D4EEQ36730207-C5580D5F-F326-4ABC-B09F-9AF1ED000BA1Q37496314-10E86E82-EF8A-45DC-A60C-449E800C9133Q37723588-ECB9A784-6D64-4D85-9307-F15913B35573Q37738294-843F2CD2-64B2-409D-892F-C907766702F9Q37888723-C864F846-9A35-4CE3-9D16-5F90C602827BQ38014346-43C0A87F-83BD-4769-BC3F-810EEBE8DC39Q38052075-601B797F-AA2F-48A8-B505-52505E74C52CQ38085657-56C01FF3-1CF3-4420-A1B7-FC50912EE77BQ38161347-4AC6C7CC-43C9-40A8-990A-523DD02744C4Q38284244-C7F06A48-0E62-4784-BE85-C7F985C56B01Q38534275-74325402-6F9C-4ED1-960E-5BED8A729AAEQ38565748-D70BA8B5-C27A-41E2-A5C0-EE194DBFFAB4Q39034928-3F7D4029-ED8D-497F-96B6-74CC9CABB7EFQ40804025-9F07B988-77F5-4EB6-9D2E-C51A5B91A61EQ41703043-B4F247DF-DAAE-44B3-8F08-460F6DA1D4B9Q42175534-3FD0AE3A-4DBA-410D-A876-A6EFF04DDC24Q46460686-3962ECE2-13EB-4D69-ADB8-E7FE0DF72A9BQ48799668-A867E23D-79EF-48D5-BD85-5449BCCD752BQ51744512-69305C99-9FC2-45CA-87E5-B610FD01567AQ53081527-C7CBF35D-004D-4F2B-ACC5-48ABAEF20452Q53757550-73B79135-B835-4CCC-B788-2CAFA1B12B5FQ55284804-A166D036-35FF-4DC9-A819-B4769C73072DQ55399619-B737CAA4-8497-45FC-819F-1F0B4FD51627Q55476876-CF44B29F-415F-4DE2-B2CA-98EEAA1FA052Q57041686-42998A29-B49C-4E74-8914-BC8705988D67Q57412648-EFCFB10A-0F42-4879-94C4-A76FC05C7AF9Q57412757-8E43B690-39F1-4159-905F-1DE75B96F53BQ58842177-C8156897-DD2F-4071-A53F-3A6BEB672C11
P2860
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
@en
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
@nl
type
label
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
@en
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
@nl
prefLabel
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
@en
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
@nl
P2860
P1433
P1476
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00125-010-1752-6
P577
2010-04-21T00:00:00Z